CN Stock MarketDetailed Quotes

Chengda Pharmaceuticals (301201)

Watchlist
  • 41.17
  • -0.90-2.14%
Market Closed May 13 15:00 CST
6.37BMarket Cap-1790.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengda Pharmaceuticals (301201) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
自主销售类产品收入238.66M58.73%
定制类产品和服务收入164.99M40.60%
Other business1.58M0.39%
贸易类收入1.13M0.28%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry240.43M59.17%
Food manufacturing industry163.22M40.17%
Other business1.58M0.39%
贸易类收入1.13M0.28%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic260.24M64.04%
Abroad146.13M35.96%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +4.07%
Sample Name
Sample Code
 +1.55%
Sample Name
Sample Code
 +1.37%
4
SINOPEC CORP
00386
+0.65%
5
CNOOC
00883
+0.08%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +67.26%
Sample Name
Sample Code
 +44.28%
Sample Name
Sample Code
 +32.47%
4
Loongson Technology Corporation
688047
+31.76%
5
Business-intelligence Of Oriental Nations Corporation
300166
+27.06%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -